Related Experiment Video
Updated: Jul 6, 2026
04:30
Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models
Published on: March 8, 2024
[Myoplegia with rocuronium bromide in children]
Anesteziologiia I Reanimatologiia
|March 29, 2008
Summary
Esmerone (rocuronium bromide) offers a safer alternative to succinylcholine for pediatric anesthesia. Higher Esmerone doses enhance neuromuscular blockade onset and duration in children aged 7-14.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Pediatric anesthesia requires effective and safe neuromuscular blocking agents.
- Succinylcholine is commonly used but can have adverse effects.
- Evaluating alternative agents like Esmerone is crucial for improving patient safety.
Purpose of the Study:
- To assess the efficacy and safety of various doses of Esmerone (rocuronium bromide) in pediatric patients undergoing anesthesia.
- To compare the effects of Esmerone with succinylcholine in children aged 7-14 years.
Main Methods:
- A study involving 85 children (7-14 years) under fluorothane anesthesia.
- Patients were divided into groups receiving either succinylcholine or different doses of Esmerone (0.3, 0.6, 0.9 mg/kg).
- Efficacy was evaluated using accelerographic and clinical data.
Main Results:
- Esmerone demonstrated a superior safety profile compared to succinylcholine.
- Increasing Esmerone dosage positively influenced the onset of neuromuscular blockade (NMB).
- Higher doses of Esmerone led to a prolonged duration of NMB.
Conclusions:
- Esmerone is a safer neuromuscular blocking agent for pediatric anesthesia than succinylcholine.
- Dose escalation of Esmerone provides predictable and extended neuromuscular blockade.
- Esmerone represents a valuable option for achieving myoplegia in pediatric surgical procedures.
Related Concept Videos
01:31Skeletal Muscle Relaxants: Therapeutic Uses
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx as...
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
01:28Depolarizing Blockers: Mechanism of Action
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
01:19Depolarizing Blockers: Pharmocokinetics
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
01:21Skeletal Muscle Relaxants: Adverse Effects
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...